Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenblum, W. I.
Right arrow Articles by Choi, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenblum, W. I.
Right arrow Articles by Choi, S. C.

Stroke, Vol 16, 980-984, Copyright © 1985 by American Heart Association


ARTICLES

Effects of estradiol on platelet aggregation in cerebral microvessels of mice

WI Rosenblum, F el-Sabban, AD Allen, GH Nelson, AS Bhatnagar and SC Choi

Mice were implanted subcutaneously with a pellet containing 0.5 mg estradiol or with a placebo. Eight to 12 days later platelet aggregation was produced in pial arterioles by injuring their endothelium in vivo with a noxious light/dye stimulus. The time between the onset of the noxious stimulus and the appearance of platelet aggregates was significantly shortened (p less than .02) by estradiol treatment in young (2 month old) mice. The same treatment had the opposite effect in 4-6 month old mice and significantly delayed the onset of aggregation (p = .01). When platelet rich plasma (PRP) was prepared, aggregation by sodium arachidonate was always inhibited in PRP from estradiol treated mice, irrespective of age. Estradiol treatment had no effect on aggregation induced ex vivo by ADP. Thus the enhanced aggregation observed in pial arterioles of young estradiol treated mice may not reflect direct effects of estradiol on the platelet itself. The data are discussed in light of the literature suggesting enhancement of ischemic vascular disease, including strokes, in patients receiving estrogens, and especially high doses of estrogens.


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
E. F. Verdu, Y. Deng, P. Bercik, and S. M. Collins
Modulatory effects of estrogen in two murine models of experimental colitis
Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G27 - G36.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Nakano, T. Oshima, H. Matsuura, G. Kajiyama, and M. Kambe
Effect of 17ß-Estradiol on Inhibition of Platelet Aggregation In Vitro Is Mediated by an Increase in NO Synthesis
Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 961 - 967.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Li, N. Futrell, J. S. Tovar, L. C. Wang, D. Z. Wang DO, and L. R. Schultz
Gender Influences the Magnitude of the Inflammatory Response Within Embolic Cerebral Infarcts in Young Rats
Stroke, March 1, 1996; 27(3): 498 - 503.
[Abstract] [Full Text]